Executive Director, HIV Global Medical Affairs
Gilead Sciences
Santa Fe, NM, United States
Joel Gallant is Executive Director of HIV Global Medical Affairs at Gilead Sciences, where he focuses primarily on HIV therapy. Before joining Gilead in 2017, he had been a professor in the Division of Infectious Diseases at Johns Hopkins University for 21 years, where he served as associate director of the HIV program. He was also a professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. He subsequently directed HIV and hepatitis services and served as acting Chief Medical Officer at Southwest CARE Center in Santa Fe, New Mexico. While there he held a faculty appointment in the Division of Infectious Diseases at the University of New Mexico School of Medicine. He has conducted clinical trials on the treatment of HIV infection and viral hepatitis and has been an investigator in the HIV Prevention Trials Network (HPTN), the Multicenter AIDS Cohort (MACS), and the AIDS Clinical Trials Group (ACTG).
Dr. Gallant received his M.D. at the University of California, San Francisco. He completed a residency and chief residency in internal medicine at Yale-New Haven Hospital. He received his M.P.H. at the Johns Hopkins University School of Hygiene and Public Health and completed a fellowship in infectious diseases at the Johns Hopkins University School of Medicine. He is a fellow in the Infectious Diseases Society of America (IDSA) and the American College of Physicians. He has served as Chair of the HIV Medicine Association (HIVMA) and was HIVMA representative on the Board of the IDSA. He was a member of the Governing Council of the International AIDS Society and served on the Board of Directors of the International Antiviral Society-USA (IAS-USA) and the Infectious Disease Specialty Board of the American Board of Internal Medicine. He was a member of the antiretroviral therapy guidelines panels of both the DHHS and the IAS-USA and also served on the IDSA/HIVMA Panel for Primary Care Guidelines for the Management of Persons Infected with HIV.
Dr. Gallant is the recipient of the 2006 HIV Clinical Educator Award from the IDSA/HIVMA. He has written and spoken extensively on HIV infection and antiretroviral therapy. Before joining Gilead, he was the author of "100 Questions and Answers about HIV and AIDS," a book for lay readers, and was editor-in-chief of the Johns Hopkins HIV Guide, a web-based educational tool.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Wednesday, October 19, 2022
8:00 AM – 12:00 PM US ET
Wednesday, October 19, 2022
10:45 AM – 12:00 PM US ET